Key facts
- This page summarizes Cassandra Louise Gorsuch's Form 3 filing for PRECISION BIOSCIENCES INC (DTIL).
- 0 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 03 Aug 2026, 07:17.
Cassandra Louise Gorsuch - 01 Aug 2026 Form 3 Insider Report for PRECISION BIOSCIENCES INC (DTIL)
- Reporting relationship
- Chief Scientific Officer
- Issuer ticker
- DTIL
- Reported as of
- 01 Aug 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Dario Scimeca, Attorney-in-Fact for Cassandra Gorsuch
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Cassandra Louise Gorsuch filed Form 3 for PRECISION BIOSCIENCES INC (DTIL) on 03 Aug 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002133497
Primary reporting owner
Gorsuch Cassandra Louise
- Relationship
- Chief Scientific Officer
- Address
- C/O PRECISION BIOSCIENCES, INC., 302 E. PETTIGREW STREET, SUITE A-100, DURHAM
- Signature
- /s/ Dario Scimeca, Attorney-in-Fact for Cassandra Gorsuch
- Signature date
- 03 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DTIL
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 16,028
- Date
- 01 Aug 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DTIL
holding
Derivative
Employee Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 235
- Exercise price
- $36.00
- Footnotes
- F1
DTIL
holding
Derivative
Employee Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 585
- Exercise price
- $359.40
- Footnotes
- F1
DTIL
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,000
- Exercise price
- Footnotes
- F2, F3
DTIL
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 179,340
- Exercise price
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Stock options are fully vested as of the date of this report
Footnote F2
On June 2, 2025, the reporting person was granted 60,000 restricted stock units ("RSUs"), which vest in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
Footnote F3
The Reporting Person was granted RSUs, which each represents a contingent right to receive one share of the Company's Common Stock.
Footnote F4
On June 1, 2026, the reporting person was granted 179,340 RSUs, which vest in three substantially equal annual installments beginning on February 19, 2027, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
SEC remarks
Exhibit 24 - Power of Attorney